GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hugel 145020.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

187,100

-0.21%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩425.11bn

FY2016FY2025

Net income

₩140.87bn

FY2016FY2025

Free cash flow

₩120.54bn

FY2016FY2025

Shareholders' equity

₩950.26bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩425.11bn₩373.05bn₩319.70bn₩281.68bn₩245.15bn₩211.04bn₩204.57bn₩182.39bn₩182.09bn₩124.19bn
Gross profit₩333.48bn₩287.18bn₩246.16bn₩218.86bn₩180.80bn₩148.79bn₩143.95bn₩131.38bn₩142.11bn₩94.40bn
Research and development₩11.70bn₩9.21bn₩11.02bn₩15.08bn₩12.62bn₩15.74bn—₩7.75bn₩6.92bn₩4.06bn
Operating income₩200.85bn₩147.80bn₩106.22bn₩94.46bn₩96.23bn₩77.42bn₩68.09bn₩85.63bn₩102.36bn₩63.25bn
Net income₩140.87bn₩135.81bn₩93.08bn₩57.33bn₩57.73bn₩41.99bn₩44.61bn₩69.74bn₩72.83bn₩43.27bn
Diluted earnings per share13,039.7112,347.568,299.884,856.264,744.193,352.513,561.655,408.3114,698.014,418.41

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩1.08trn₩939.44bn₩929.25bn₩1.05trn₩1.01trn₩956.34bn₩894.69bn₩918.27bn₩820.93bn₩294.30bn
Cash and short-term investments—₩421.42bn₩479.18bn₩523.99bn₩552.13bn₩599.20bn₩568.90bn₩601.55bn₩595.70bn₩104.12bn
Total liabilities₩96.68bn₩98.63bn₩149.57bn₩257.67bn₩232.65bn₩209.67bn₩195.19bn₩190.55bn₩125.22bn₩41.50bn
Debt—₩37.61bn₩90.52bn₩100.70bn₩98.40bn₩93.60bn₩91.50bn₩82.93bn₩79.57bn₩300.0m
Shareholders' equity₩950.26bn₩803.78bn₩747.31bn₩792.11bn₩777.09bn₩746.67bn₩699.50bn₩727.72bn₩695.71bn₩252.80bn
Shares outstanding11m11m11m12m12m13m13m13m5m10m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩150.06bn₩149.05bn₩117.71bn₩80.63bn₩85.94bn₩74.30bn₩76.99bn₩65.80bn₩64.19bn₩45.14bn
Capital spending−₩29.52bn−₩33.31bn−₩40.56bn−₩32.82bn−₩23.88bn−₩16.98bn−₩12.28bn−₩9.10bn−₩6.34bn−₩16.09bn
Free cash flow₩120.54bn₩115.74bn₩77.15bn₩47.80bn₩62.06bn₩57.33bn₩64.71bn₩56.69bn₩57.85bn₩29.05bn
Dividends paid——−₩105.9m———————

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩137.90bn₩116.64bn₩119.13bn₩105.90bn₩110.26bn₩89.82bn₩98.21bn₩105.11bn
Gross profit₩105.76bn₩90.08bn₩96.18bn₩81.66bn₩86.62bn₩69.02bn₩75.72bn₩82.86bn
Operating income₩56.03bn₩47.62bn₩57.83bn₩47.40bn₩56.67bn₩38.95bn₩29.43bn₩52.30bn
Net income₩43.34bn₩39.25bn₩38.57bn₩36.81bn₩36.43bn₩29.06bn₩39.97bn₩40.26bn
Diluted earnings per share4,011.733,633.603,570.173,408.173,373.852,700.573,712.803,660.47
Cash from operations₩40.88bn₩57.43bn₩64.74bn₩18.38bn₩26.31bn₩40.62bn₩46.46bn₩46.83bn
Capital spending−₩17.82bn−₩14.33bn−₩6.74bn−₩3.70bn−₩8.51bn−₩10.56bn−₩18.04bn−₩3.26bn
Free cash flow₩23.07bn₩43.11bn₩58.01bn₩14.68bn₩17.80bn₩30.05bn₩28.42bn₩43.57bn
Total assets₩1.19trn₩1.13trn₩1.08trn₩1.03trn₩1.01trn₩973.02bn₩939.44bn₩942.96bn
Cash and short-term investments—————₩465.38bn₩421.42bn₩454.82bn
Debt————₩25.11bn₩34.55bn₩34.84bn₩34.90bn
Shareholders' equity₩1.06trn₩1.00trn₩950.26bn₩905.63bn₩859.29bn₩839.41bn₩803.78bn₩817.08bn

Financial ratios

Data as of 27 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin78.4%77.0%77.0%77.7%73.7%70.5%———
Operating margin47.2%39.6%33.2%33.5%39.3%36.7%———
Net margin33.1%36.4%29.1%20.4%23.5%19.9%———
Return on equity14.8%16.9%12.5%7.2%7.4%5.6%———
Return on assets13.1%14.5%10.0%5.5%5.7%4.4%———
Free cash flow yield———————2.4%5.8%
Revenue growth14.0%16.7%13.5%14.9%16.2%3.2%———
Earnings growth3.7%45.9%62.3%-0.7%37.5%-5.9%———
Current ratio7.30x8.56x9.89x3.48x11.40x15.27x———
Debt to equity—0.03x0.12x0.00x0.12x0.12x0.12x——
Equity ratio88.2%85.6%80.4%75.5%77.0%78.1%———
Interest coverage177.73x125.41x36.17x30.36x25.86x21.16x———
R&D as a share of sales2.8%2.5%3.4%5.4%5.1%7.5%———
Buybacks as a share of market value———————-160.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.7%15.0%20.6%
Operating income28.6%21.0%11.4%
Net income34.9%27.4%15.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin77.8%77.6%76.3%75.2%
Operating margin43.7%39.3%39.0%42.5%
Net margin34.7%30.5%28.4%30.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings17.722.718.027.832.456.937.828.215.229.0
Price to sales5.98.35.25.77.611.38.210.86.110.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-for-1 split · 8 Jul 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.